Weekly Digest - September 2024
CAR-T Digest - August 2020
CAR-T Digest - August 2020
CAR-T Digest - August 2020
CAR-T Digest - August 2020
Weekly Digest - September 2024
3 Sep 2024: AstraZeneca drives progress in enhancing cancer care standards across multiple cancer types at WCLC and ESMO 2024
- AstraZeneca will present new data at the IASLC 2024 World Conference on Lung Cancer (WCLC) and ESMO 2024, featuring over 130 abstracts and 17 approved or potential new medicines
- Focus includes early intervention, antibody drug conjugates (ADCs) replacing chemotherapy, and advanced immunotherapy treatments
- Key presentations will feature results from trials involving IMFINZI, TAGRISSO, ENHERTU, and datopotamab deruxtecan across lung, breast, bladder, and other cancers
- AstraZeneca emphasizes collaboration with companies like Daiichi Sankyo, Merck, and HUTCHMED to drive innovation in cancer care
